SNFT (21 kDa small nuclear factor isolated from T cells) is a human basic leucine zipper transcription factor that can repress AP-1-mediated transcription. We show here that overexpression of p21 SNFT in HepG2 cells leads to repression of matrix metalloproteinase-1 by 70-80%. p21
Introduction
Enhanced activity of the interstitial collagenase matrix metalloproteinase-1 (MMP-1) has been correlated with greater metastases and poorer prognoses of several types of cancer (Murray et al., 1996 (Murray et al., , 1998 Inoue et al., 1999; Ito et al., 1999; Sunami et al., 2000) . While the activity of MMP-1 is regulated at several levels, control of MMP-1 transcription at the proximal 600 bp region of the promoter is significant and highly characterized (Angel et al., 1987; Gutman and Wasylyk, 1990; Jonat et al., 1992; Borden and Heller, 1997; Westermarck et al., 1997; Chapman et al., 1999; Nagese and Woessner, 1999; Westermark and Kahari, 1999) . A major enhancer element of the promoter is the À88 Ets/AP-1 composite element. This element consists of a consensus AP-1 site, first identified as a 12-O-tetradecanoyl-phorbol-13-acetate (TPA) responsive element (TRE) (Angel et al., 1987) , adjacent to a nonconsensus Ets-binding element. Ets and AP-1 proteins have been shown to bind and transactivate transcription from this element alone and together (Angel et al., 1987; Gutman and Wasylyk, 1990; Buttice et al., 1996; Chapman et al., 1999; Ozaki et al., 2002) . p21 SNFT (21 kDa small nuclear factor isolated from T cells) is a basic leucine zipper (bZIP) transcription factor that can dimerize with Jun and repress AP-1-mediated transcription (Iacobelli et al., 2000; Bower et al., 2002) . Of several AP-1 dependent genes tested, only interleukin-2 (IL-2) responded to p21
SNFT by greater than 50% (Iacobelli et al., 2000) . We have proposed that this specificity may reflect higher order interactions between AP-1 and other transcription factors with DNA at composite promoter elements (Bower et al., 2002) .
As the MMP-1 gene is controlled transcriptionally at a composite binding site, we hypothesized that p21 SNFT might repress this gene, as it does IL-2. The data presented here demonstrate that MMP-1 transcription is largely reduced in p21 SNFT -overexpressing HepG2 hepatocarcinoma cells, and that repression is likely to occur at the À88 Ets/AP-1 element. In the presence of Ets proteins, p21 SNFT /Jun dimers protect DNA differently than Fos/Jun dimers, suggesting that a unique conformation of the higher order complex may be involved in repression by p21 SNFT . Overexpression of p21
SNFT and repression of MMP-1 led to a decrease in the invasiveness of cancer cells in tissue culture. The results indicate that p21
SNFT may display anticancer activity due, at least in part, to the transcriptional repression of MMP-1.
Results

p21
SNFT represses MMP-1 promoter activity and transcription of MMP-1
To evaluate MMP-1 promoter activity in the presence of p21 SNFT , transient transfection assays were performed in the HeLa cervical cancer line, in which p21
SNFT has been shown to localize to the nucleus (Bower et al., 2002) . As shown in Figure 1 , luciferase activity was produced by the proximal 600 bp region of the MMP-1 promoter in response to TPA stimulation. Promoter activity was repressed up to 40-60% in response to p21
SNFT expression from either a green fluorescence protein (GFP)-tagged or untagged (pCIneo) p21 SNFT expression construct.
To evaluate the effect of p21 SNFT on endogenous MMP-1 expression, we generated three lines of HepG2 hepatocarcinoma cells stably expressing p21 SNFT (HepG2SNFT-1, -2, and -3) and three control lines stably expressing empty vector (HepG2neo-1, -2, and -3). Total RNAs were isolated from TPA-stimulated cells and reverse transcriptase (RT)-PCR analyses were performed. p21
SNFT mRNA levels were greatly increased as expected in overexpressing lines (Figure 2a, top, lanes 8, 10, and 12) relative to controls (lanes 2, 4, and 6). Western blot analysis showed that p21 SNFT protein levels were also greatly increased in these cells, while in the control cells p21
SNFT protein could not be detected (Figure 2b, lower) . Semiquantitative PCR showed that HepG2 cells expressed only B1% of the mRNA for p21
SNFT made by the overexpressing cells (Figure 2b, upper) . When the effect of p21 SNFT on MMP-1 transcription was evaluated, the amount of MMP-1 mRNA detected in HepG2SNFT lines was much lower than that of the controls, with the HepG2SNFT-1 line producing no detectable MMP-1 mRNA (Figure 2a, middle) . In contrast, the levels of mRNA encoding the L32 ribosomal protein are similar in all the six cell lines (Figure 2a, bottom) . Semiquantitative PCR (Figure 2c ) suggests that the overexpression of p21
SNFT leads to at least a 90% repression of MMP-1 transcription. In Western blot analyses probed for MMP-1 (Figure 2d ), the HepG2SNFT-1 cell line showed no detectable MMP-1 protein, consistent with the lack of mRNA (Figure 2a ). While HepG2SNFT-2 and HepG2SNFT-3 produced detectable MMP-1 protein as well as mRNA, levels were reduced in both of these lines relative to all the three control lines, demonstrated at two time points. The average percent repression of MMP-1 protein for HepG2SNFT relative to HepG2neo cells was approximately 83%. Together, the data demonstrate that overexpression of p21 SNFT leads to a significant transcriptional inhibition of MMP-1 and this inhibition extends to the protein level.
SNFT physically interacts at the MMP-1 promoter region
In chromatin immunoprecipitation (ChIP) assays, the MMP-1 promoter region (À166 to þ 61) is effectively amplified from total chromatin (Figure 2e, top panel, total) and from chromatin immunoprecipitated with anti-p21 SNFT antiserum (Ab). To determine if the small amount of product detected in samples incubated with preimmune serum (no Ab) was due to nonspecific chromatin contamination, PCR of pim-1 (a gene that does not interact with p21 SNFT ) was performed on the same samples. These results show that the level of nonspecific chromatin contamination is similar in the 'no Ab' and 'Ab' samples, strongly suggesting that the increase in MMP-1 PCR product observed in the presence of antibody is due to a specific interaction of p21 SNFT with the MMP-1 promoter.
SNFT represses the MMP-1 promoter at the À88 Ets/AP-1 composite enhancer element
As p21
SNFT has been suggested to interact at composite AP-1 promoter elements, we hypothesized that the À88 Ets/AP-1 enhancer element of the MMP-1 promoter would be repressed in response to the protein (Bower et al., 2002) . HeLa cells were transiently cotransfected with chloramphenicol acetyltransferase (CAT) constructs driven by the element in triplicate, and with p21 SNFT expression construct as indicated ( Figure 3a ). As previously demonstrated (Chapman et al., 1999) , in the absence of p21 SNFT (0 mg), the Ets mutant construct promotes approximately 20-25% of the CAT activity produced by the wild-type element, while the AP-1-binding region mutant is inactive. In response to p21 SNFT , the wild-type element is repressed up to 75-80% and the Ets-binding region mutant is repressed to basal levels. The results demonstrate that p21 SNFT can repress this element, and the observation that the Ets mutant is repressed suggests that repression occurs at the AP-1-binding region.
Nuclear extracts isolated from stimulated HepG2SNFT and HepG2neo cell lines were used to evaluate DNA-binding activity at this element in EMSA analyses. Two complexes are formed using p21 SNFT -overexpressing extracts (Figure 3b , right arrows), although only the upper complex is seen using control extracts (left arrow). Both complexes were effectively competed in the presence of unlabeled Ets/AP-1 site or a different TRE (lacking an Ets-binding site). In contrast, an NFkB-binding site failed to disrupt either major complex, demonstrating that both complexes are specific for the AP-1-binding site. Moreover, Figure 3c shows that using p21 SNFT -overexpressing extracts, the lower molecular weight complex (lanes 3, 5, and 7) is effectively supershifted by a p21 SNFT -specific antiserum (lanes 4, 6, and 8, asterisk), while the upper complex remains. In contrast, no supershift is observed in the presence of antiserum using control extracts (lanes 1 and 2) despite a partial blocking of the complex, which is consistent with the lack of p21 SNFT expression in these cells. The data demonstrate that the lower complex contains p21 SNFT , while the upper complex does not. In Figure 3d , antisera specific to c-Jun is shown to significantly block the formation of the two complexes using both HepG2neo and HepG2SNFT extracts, and a slight supershift is observed (lanes 2 and 7, asterisk). Antisera to JunB leads to substantial blocking of the complexes as well, although no supershift is observed with this antisera (lanes 3 and 8). These data suggest that c-Jun and JunB are the major Jun family partners in these complexes, but a minor supershift with the JunD antisera is also seen (lanes 4 and 9). These data confirm the presence of Jun proteins in these complexes. A supershift is also observed using both nuclear extracts in the presence of antisera specific to c-Fos (lanes 5 and 10, double asterisk), consistent with the fact that the upper (AP-1) complex appears using both extracts (Figure 3b and c). and the fact that relative MMP-1 levels are congruous at both time points. Quantitation (bottom) was performed using laser densitometry. A representative gel of three experiments is shown. (e) Chromatin immunoprecipitation assays using a chicken a-p21 SNFT antiserum (Ab) or pre-immune antiserum from the same chicken (no Ab). 'Mock' samples contained buffer instead of chromatin in the immunoprecipitation reaction, while 'no chrom' samples did not include chromatin in the PCR reaction. 'Total' samples used a 1/300 dilution of chromatin isolated from the supernatant of 'no Ab' immunoprecipitation (other samples were used undiluted). PCR reactions specific to the MMP-1 (top) or pim-1 (bottom) promoter regions are shown. Data are representative of two independent experiments
Transcriptional repression of MMP-1 by p21
SNFT /Jun dimers interact at the -88 Ets/AP-1 element of the MMP-1 promoter in the presence of Ets-1
In EMSA analyses using purified proteins (Figure 3e ), free probe (run off the gel shown) is not shifted by Fos or p21 SNFT , alone or together, but both heterodimerize and bind DNA with Jun, as do Jun homodimers (lanes 1-5, 10, and 14). As previously observed (Bower et al., 2002) , the AP-1 heterodimer forms a doublet with the upper complex migrating similarly to a Jun homodimer.
Transcriptional repression of MMP-1 by p21 SNFT Additionally, purified Ets-1 DNA-binding domain independently monomerizes at this element, and neither Fos nor p21 SNFT alone is able to interact with the Ets/DNA complex (lanes 6-8). However, the addition of Ets-1 to Jun homodimers (lane 9), AP-1 heterodimers (lane 11), and p21 SNFT /Jun heterodimers (lane 13) produced a higher migrating complex consisting of both Ets and the bZIP dimer bound to the same piece of DNA. The independent DNA-bound Ets monomer and bZIP dimers are evident in these lanes as well. Finally, the inclusion of all the four proteins together permits the formation of each complex seen in other lanes, but does not result in any new complexes (lane 12). Thus, Ets monomer can coexist at this element with Jun homodimer, AP-1 or p21 SNFT /Jun heterodimer, but only one dimer can occupy a single piece of DNA. These data show that p21
SNFT can bind to the Ets/AP-1 element with Jun and Ets just as Fos can. Collectively, the results presented in Figure 3 demonstrate that p21
SNFT can bind to the AP-1 portion of the Ets/AP-1 element from the MMP-1 promoter and repress its activity.
A p21
SNFT /Jun/Ets complex footprints the À88 Ets/AP-1 element of the MMP-1 promoter differently than an Ets/AP-1 complex Purified proteins were used in DNase I footprint analyses of the MMP-1 promoter À88 Ets/AP-1 element sense ( Figure 4a ) and antisense (Figure 4b ) strands. Sequencing reactions were used to identify the Ets (EBS) and AP-1 (TRE) binding sites as indicated, and Jun was used in all reactions at a concentration insufficient to homodimerize (lane 2 versus 1). In the presence of Jun, titration of either Fos or p21
SNFT produces an AP-1 or p21 SNFT /Jun heterodimer (lanes 3-5 and 6-8, respectively), evidenced by a protection of the TRE and the production of hypersensitive sites in the flanking regions. When Fos is held constant at the highest concentration (from lane 5) and Ets is titrated into the reaction the TRE remains protected, while a footprint of the EBS is produced as well (lanes 9-11). For comparison, protection of the EBS by Ets is shown independently in lanes 15-16. In contrast, while a titration of Ets into the p21 SNFT /Jun reaction (from lane 8) results in gradual protection of the EBS (lanes 12-14), a progressive deprotection of the TRE and flanking bases is observed concurrently. This deprotection is clearly seen on the sense strand (Figure 4a ), but is not observed on the antisense strand (4b) of DNA. The results strongly suggest that protein : DNA interactions at this element are very different when p21 SNFT versus Fos is present.
In Figure 4c , in vitro cooperativity of the Ets/AP-1 and Ets/p21 SNFT /Jun complexes was measured using quantitative EMSA. The reactions shown in Figure 3e (lanes 11 and 13) were repeated and radioactivity in each band was quantitated. As summarized in Table 1 SNFT and Jun is more efficient than with Fos and Jun under these conditions at the -88 Ets/AP-1 element. Thus, the progressive deprotection of the TRE that accompanies the formation of Ets/p21 SNFT /Jun/ DNA complexes is due to a difference in protein : DNA interactions rather than a lack of DNA binding.
Overexpression of p21
SNFT and immunodepletion of MMP-1 cooperatively inhibit the invasiveness of HepG2 cells through type I collagen
To evaluate the effect of p21 SNFT overexpression on cell behavior, in vitro invasion assays were performed on type I collagen, and show that TPA-stimulated HepG2SNFT cells were reduced for invasiveness by approximately 50% relative to HepG2neo cells (Figure 5a ). The addition of 1 mg/ml anti-MMP-1 antibody to the control samples decreased invasiveness by an amount comparable to p21
SNFT overexpression, while a much higher concentration almost totally abrogated invasion. A control rabbit IgG antibody did not significantly inhibit the ability of HepG2neo cells to invade. In combination with the overexpression of p21 SNFT , the lower anti-MMP-1 antibody concentration led to the almost total absence of invasiveness, while control IgG did not. In all cases, the reductions in response to anti-MMP-1 antibody and overexpression of p21
SNFT are statistically significant (Po0.005). The slight reduction observed in response to control IgG antibody is not significant using either control or p21 SNFT -overexpressing cells (P>0.1). The data show that reduction via overexpression of p21 SNFT is able to complement reduction via immunodepletion with anti-MMP-1 antibody; hence, the reduced invasiveness through type I collagen observed in p21 SNFT overexpressing cells is likely to reflect the reduction of MMP-1.
Overexpression of p21 SNFT inhibits the invasiveness of HepG2 cells through Matrigel
HepG2neo and HepG2SNFT lines were also plated in Matrigel Invasion Chambers to determine if p21 SNFT can affect the ability of cells to invade through reconstituted basement membranes. Figure 5b reveals that invasion of stimulated HepG2SNFT cells through a Matrigel was reduced by approximately 50% relative to control lines in these assays. The results show that overexpression of p21 SNFT leads to a significant reduction in the invasive phenotype of these cells (Po0.005).
Growth curves of the HepG2SNFT and HepG2neo lines were evaluated by plating each line at a starting concentration of 10 5 cells per ml. For four passages over the course of 2 weeks, cells were plated to the same starting concentration at each passage, and the fold increase was recorded for each line. As shown in Figure 5c , overexpression of p21 SNFT does not affect the overall growth rate of HepG2 cells relative to controls. The data suggest that the effects of p21 SNFT reflect a true decrease in invasive behavior, rather than a change in mitotic rates or apoptosis.
To determine whether the reduction in invasiveness observed in response to p21
SNFT was specific to MMP-1 inhibition, RT-PCR analyses were performed for SNFT (S), and His 6 Ets-1 (E) proteins on the sense strand of the MMP-1 promoter. Digestion of free probe (P) is shown in lane 1, and the EBS and TRE are indicated. Jun was held constant in lanes 2-14, while Fos was titrated in lanes 3-5 and held constant in lanes 9-11. p21
SNFT was titrated in lanes 6-8 and held constant in lanes 12-14. Ets-1 was titrated in lanes 9-11, 12-14, and 15, 16. (b) DNase I footprint of the antisense strand. Binding reactions are the same as in (a). (c) EMSA analyses identical to those shown in lanes 11 and 13 of Figure 3e . Percentage of labeled probe bound to Ets, Fos, and Jun (A/E) or to Ets, p21 SNFT , and Jun (E/S/J), to Fos/Jun (AP-1) or p21 SNFT /Jun (S/J) dimer or to Ets monomer (E) was calculated, as well as the percent that was not bound (F). A representative of two gels is shown, and data from both gels were averaged in calculations of cooperativity (shown in Table 1 ) Kim et al., 2001; Blanc et al., 2002) , we were unable to detect MMP-2, MMP-8, MMP-9, or MMP-13 from our HepG2 cells; in contrast, these MMPs were easily detected from control RNAs using the same primers under identical conditions. This observation suggests that repression of MMP-1 by p21 SNFT is likely to be a major mechanism for the observed reduction in invasiveness of the p21 SNFT -overexpressing cells.
Discussion
The data presented here demonstrate that overexpression of p21 SNFT in HepG2 cells leads to the significant repression of MMP-1 transcription via interaction at the MMP-1 promoter. Chromatin immunoprecipitation showed that p21 SNFT binds the region from À166 to þ 61, either directly or via protein : protein interactions with other transcriptional machinery. Additionally, p21
SNFT was shown to repress both the À88 Ets/AP-1 element and a larger 600 bp region of the promoter. Together, the results strongly suggest that repression of MMP-1 by p21
SNFT occurs, at least in part, at the À88 Ets/AP-1 element.
EMSA analyses using nuclear extracts reveal two complexes at the À88 element under conditions of p21 SNFT overexpression, and that the lower complex contains p21
SNFT while the upper does not. The fact that no p21 SNFT -containing complex is observed in control HepG2 cells is consistent with the lack of detectable p21 SNF protein in these lines. We also used antisera specific for different Fos and Jun family members to demonstrate that c-Jun and JunB are the major dimer partners for p21 SNFT , as for Fos, in these cells. These TRE-specific complexes are extremely similar to those seen previously using nuclear extracts from Jurkat cells (Iacobelli et al., 2000) . In those studies, it was shown that the upper complex contained Fos/Jun heterodimers while the lower complex contained p21 SNFT /Jun heterodimers. Collectively, the data confirm that the complexes seen in Figure 3b SNFT and c-Fos activity. It is reasonable to speculate that Fos-containing complexes activate and p21
SNFT -containing complexes repress transcription from AP-1-dependent elements, although it is not known what other proteins may also contribute to these dynamics. Growth of HepG2neo-1, -2, and -3 was compared to that of HepG2SNFT-1, -2, and -3. Cells were counted in duplicate fields using Eosin viable dye. (d) RT-PCR analyses of MMP-2, MMP-8, MMP-9, and MMP-13 from HepG2neo, HepG2SNFT, and control RNAs. Control RNA used was from chicken embryo fibroblasts for MMP-2, Jurkat for MMP-8 and MMP-9, and HeLa for MMP-13. Molecular weight markers (MW) are indicated Footprint analyses on the À88 Ets/AP-1 element of the MMP-1 promoter indicate that, when bound to DNA together, Ets and Fos/Jun dimers may adopt a conformation somewhat different from Ets and p21 SNFT Jun dimers. A similar difference in footprint was observed on the IL-2 promoter, the only other promoter known to date to respond significantly to p21 SNFT . Interestingly, the footprint patterns of AP-1 and p21 SNFT /Jun dimers are very similar on both promoters in the absence of additional transcription factors interacting at adjacent sites (Bower et al., 2002) . The data support the hypothesis that interaction of other transcription factors with the p21 SNFT /Jun dimer at composite elements may be required for the difference in footprint and, possibly, for repression. If true, this suggests that very specific combinatorial requirements must be met within a cell in order for p21
SNFT to function in this capacity, indicating a plausible explanation for the fact that AP-1 responsiveness is not sufficient to render a promoter susceptible to inhibition by p21 SNFT . It is shown here that the reduction in MMP-1 by p21
SNFT is correlated with a decrease in the invasiveness of hepatocarcinoma cells in vitro. As type I collagen is a substrate for only a few MMPs including MMP-1, MMP-8, and MMP-13 (Matrisian, 1990; Borden and Heller, 1997; Curran and Murray, 1999) , and neither MMP-8 nor MMP-13 was detected in our cells, the reduction in MMP-1 by p21
SNFT is likely to be the mechanism for the observed decrease in collagen degradation. The results using anti-MMP-1 antibody support this hypothesis, as a decrease in invasion via immunodepletion of MMP-1 complements one produced via overexpression of p21 SNFT . Additionally, studies using Matrigel demonstrate that p21 SNFT -overexpressing cells are also reduced in their ability to degrade a reconstituted basement membrane in vitro. While these studies may reflect the repression of proteases other than MMP-1, it is likely that MMP-1 is involved. Basement membrane is known to be a major substrate for gelatinases (e.g. MMP-2 and MMP-9) and it is known that collagenase (e.g. MMP-1) degradation of native collagens can produce substrates for gelatinases (Mengshol et al., 2002) . Conversely, MMP-1 can be activated by other MMPs as well (Matrisian, 1990; Curran and Murray, 1999) . As neither MMP-2 nor MMP-9 were detected in our cells, it is likely that the reduction in Matrigel invasiveness observed in response to p21
SNFT reflects the reduction in MMP-1; other enzymes (e.g. the membrane-bound MT-MMPs) may be involved as well.
As a final note, it has been suggested that transcriptional control of MMP levels may be a highly effective target in cancer therapeutic design; yet, no drug that specifically inhibits MMP transcription has been described to date (Mengshol et al., 2002) . If repression by p21 SNFT is indeed relatively specific, as it appears to be, these results may demonstrate the molecular mechanism of a natural product that could be exploited in designing novel anticancer therapeutics.
Materials and methods
Plasmids
The pEGFP-SNFT, pQE30Fosdb, pQE32Jundb (Bower et al., 2002) , pCI/SNFT, GST-SNFT (Iacobelli et al., 2000) , his-Ets-1 DBD (Nikolajczyk et al., 1996) , and Ets/AP-1-CAT wildtype and mutant constructs (Chapman et al., 1999) have been described previously. The MMP-1 promoter luciferase construct was generated by cloning the human MMP-1 promoter region (À610 to þ 61) from the pUC9pCllase II genomic cosmid (Angel et al., 1987) into the pGL3basic luciferase vector (Promega Corp., Madison, WI, USA) multiple cloning site.
Transfections
For MMP-1 promoter and Ets/AP-1 enhancer studies, transient transfections in HeLa cells were performed using the LipofectAMINE Plus kit (Invitrogen Corp., Carlsbad, CA, USA). Total DNA concentration was kept constant using empty pCIneo vector or pEGFP (GFP expression vector). At 20 h post-transfection, cells were stimulated with 50 ng/ml TPA and harvested 20 h later. Luciferase and CAT assays were performed as described (Curtiss et al., 1996) .
To generate HepG2 cell lines stably overexpressing p21 SNFT (HepG2SNFT-1, -2, and -3), HepG2 cells were transfected in triplicate with pCI/SNFT, via LipofectAMINE Plus kit. Control lines (HepG2neo-1, -2, and -3) were transfected with empty pCIneo vector. Following selection with 1 mg/ml G418, all lines were maintained using 500 mg/ml G418.
RT-PCR
Subconfluent cultures of HepG2SNFT and HepG2neo lines were stimulated for 13 h with 50 ng/ml TPA. Following stimulation, total RNA was isolated using RNA- Inc. Friendswood, TX) . RNA was treated with RQ1 DNase I (Promega) for 1 h at 371C and cDNA was generated using the Reverse Transcription System (Promega) with oligo (dT) priming. PCR was performed using recombinant Taq polymerase from TaKaRa (Shiga, Japan), utilizing primer sets that primed each coding region over at least one intron. Primer sequences are given in Table 2 . For semiquantitative PCR (Figure 2b and c), cDNAs generated from control or p21 SNFT -overexpressing cells were diluted as indicated and run in PCR reactions parallel to undiluted experimental cDNAs from the other cell type. The amount of product generated in the experimental samples was estimated by comparing directly to the diluted controls.
Western blots
Western blots for MMP-1 were performed using media harvested from subconfluent HepG2neo and HepG2SNFT cell lines in 100 mM plates. Cells were washed out of serum and stimulated with 50 ng/ml TPA. In all, 1 ml of media from each line was harvested at 16 and 24 h post-stimulation, concentrated by SpeedVac (Savant Instruments, Farmingdale, NY, USA) and 10 mg total protein were loaded to SDS-PAGE gels. Western blots were performed exactly as described previously for blots probed for GFP (Bower et al., 2002) , except that the primary antibody used was rabbit polyclonal a-MMP-1 (Chemicon Intl., Temecula, CA, USA) diluted 1 : 1000 in 5% milk/TBST (20 mM Tris (pH 7.6), 140 mM NaCl, 0.1% Tween20). Average protein levels were calculated by taking the average of all the three control or p21
SNFT overexpressing lines over both time points.
Western blots for p21
SNFT were identical to those for MMP-1, except that cells were stimulated for 4 h or left unstimulated; nuclear extracts were prepared as described (McGuire and Iacobelli, 1997) and 100 mg of extract were used from each cell line. The primary antibody was chicken a-SNFT antiserum (#12), generated by immunizing chickens with purified GST-SNFT and isolated from eggs as previously described (Tini et al., 2002) , except that no affinity purification was used. a-SNFT #12 was diluted 1 : 4000 in 5% milk/TBST, and the secondary antibody was rabbit a-chicken-HRP (Sigma) diluted 1 : 10 000 in 5% milk/TBST.
Chromatin immunoprecipitation assays
Subconfluent cultures of HepG2SNFT#1 cells were stimulated for 4 h with 50 ng/ml TPA. Chromatin immunoprecipitation was performed essentially as described (http://mcardle.oncology.wisc.edu/farnham/protocols/chips.html) using a protocol modified from Weinmann et al. (2001) . p21
SNFT was immunoprecipitated using chicken a-SNFT antiserum #12 (described above) and rabbit a-chicken Ig (Sigma), while 'no antibody' control samples were incubated in the presence of chicken #12 pre-immune antiserum. In lieu of Staphylococcus aureus protein A-positive cells, a 10% slurry of protein A sepharose beads in phosphate-buffered saline was used. PCR primer sequences are given in Table 2 .
Protein purification
Purification of GST-SNFT (Iacobelli et al., 2000) , His 6 Fosdb, and His 6 Jundb (Bower et al., 2002) has been described previously. To purify His 6 -Ets-1 DNA-binding domain (DBD), BL21 Escherichia coli cells containing the plasmid were cultured in Luria broth containing 100 mg/ml ampicillin at 371C, 255 r.p.m. to an A 600 of 0.6. Protein expression was induced with 0.4 mM isopropyl-b-D-thiogalactopyranoside for 4 h. His 6 -Ets-1 DBD was purified to B90% using the QiaExpressionist kit (Qiagen Inc., Valencia, CA, USA). Protein concentrations were determined using Biorad (location) Bradford assay, and purities were assessed using SDS-PAGE, followed by Coomassie Blue staining. Activities were verified by EMSA analyses.
Electrophoretic mobility shift assays and DNase I footprinting
The consensus TRE (12) and PEA3 (33) consensus Ets-binding site double-stranded oligonucleotide EMSA probes have been described previously. The Ets/AP-1 probe contained the sequence 5 0 -gatcCAAGAGGATGTTATAAAGCATGAGTC AGACAgatc-3 0 (sense). EMSA analyses and DNase I footprinting of the human MMP-1 promoter were performed as described, using 25 000 c.p.m./lane of labeled probe (Bower et al., 2002) . Nuclear extract preparation was described above for p21 SNFT Western blots. Where indicated, binding reactions were pre-incubated with 1 mg/ml of c-Fos, c-Jun, JunB or JunD specific antisera (Santa Cruz Biotechnolgies, Santa Cruz, CA, USA) for 10 min at room temperature before adding probe.
For cooperativity studies, EMSA analyses were performed as above using purified proteins. Gels were exposed to PhosphorImager cassette (Molecular Dynamics, Piscataway, NJ, USA) and Imagequant software (Amersham Pharmacia Biotech, Piscataway, NJ, USA) was used to quantitate the radioactivity present in each band. The cooperativity constant (o) was calculated as described (Fried, 1989 ) using the equation:
Briefly, because p21 SNFT /Jun and Fos/Jun complexes are obligate dimers, they constitute one component, while the Ets monomer constitutes the other. Therefore, P 0 represents the percent of free (unbound) probe, P CD the Ets/Fos/Jun/ DNA or Ets/p21 SNFT /Jun/DNA quaternary complex as indicated, P C an independent DNA-bound Fos/Jun or p21 SNFT / Jun dimer and P D an independent DNA/Ets complex. A value for o>1 indicates binding cooperativity, a value of 1 a lack of cooperativity, and a value o1 that the two components inhibit one another for binding.
Type I Collagen invasion assays
Type I Collagen invasion assays were performed using 8 mM pore size control inserts coated with 40 ml/insert of Cellagen Solution AC-3 (ICN Biomedicals, Aurora, OH, USA) diluted to 500 mg/ml in M199 medium þ 0.03% L-glutamine. Collagen matrix was permitted to solidify at 371C, 5% CO 2 for 1 h prior to cell seeding. 5 Â 10 4 cells were seeded per insert in 500 ml of serum-free Dulbecco's modified Eagle's medium (DMEM) þ 0.3% L-glutamine þ 500 mg/ml G418. The lower chamber contained 750 ml of the same media with the addition of 10% fetal bovine serum. Chambers were incubated for 24 h at 371C in 5% CO 2 and then stimulated with 50 ng/ml TPA or left unstimulated. At 20 h post-stimulation, membranes were scrubbed, fixed and stained with methanol and Toluidine according to the Matrigel Invasion Assay protocol (BD Biosciences, Medford, MA, USA). Triplicate fields were counted at Â 200 magnification and averaged for each sample. Where indicated, rabbit polyclonal a-MMP-1 antibody or rabbit IgG (Sigma) was added at the time of stimulation. 
Matrigel invasion assays
Invasion assays through Matrigel (BD Biosciences) were performed using 8 mM pore size Matrigel inserts according to the manufacturer's protocol. Cell seeding and stimulation conditions, fixing, staining and counting of cells were identical to Type I Collagen invasion assays. Statistical analyses were performed using Student's t-test. Invasion of p21 SNFT -overexpressing cells in the absence of antibody, and of control cells in the presence of antibody, were compared to that of control cells in the absence of antibody. Invasion of p21 SNFT -overexpressing cells in the presence of antibody was compared to that in the absence of antibody.
